This hour of markets now. Connell governor christie wrapping up a news conference, so we are ready to go on markets now. Dagen you were treating last night. Connell people staring at these devices. We will talk that in a minute. Now to the market first of all before we get through any of that, Nicole Petallides, good morning. Nicole good morning, connell and taken. We started off with a very tough job this morning, less than anticipated coupled with Participation Rate, the challenges of 1977. The economy is not as good as people thought it was. The dow is in the negative territory right now. 16,014. The nasdaq higher slightly. Most of the names have down arrows, some squeezing out some gains. Take a look at intercepts, pharma up 300 . On a Liver Disease drug, tacking on further gains. Back to you. Dagen the jobs report last month was terrible. People were expected the fewest number we have seen in less than three years. The Unemployment Rate did fall to lowest since october, 2008. That
Adli Destek ve Maðdur Hizmetleri Yönetmeliði memurlar.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from memurlar.net Daily Mail and Mail on Sunday newspapers.
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2020
News provided by
Share this article
Share this article
VANCOUVER, BC and HOUSTON, Feb. 11, 2021 /PRNewswire/ - ESSA Pharma Inc. ( ESSA , or the Company ) (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported financial results for the fiscal first quarter ended December 31, 2020. All references to $ in this release refer to United States dollars, unless otherwise indicated. ESSA s series of accomplishments over the past calendar year have included raising $48.9 million in an over-subscribed public offering, the granting by the U.S. Food and Drug Administration (the FDA ) of Fast Track Designation to our lead product candidate EPI-7386, and the initiation of a Phase 1 trial with EPI-7386 for patients with metastatic castration-resistant
separate limited partnerships
Certain entities are exempt from providing beneficial owner
information, including (i) an entity which is wholly owned by
another entity or an organisation (being a body that is equivalent
to an entity but which is formed under the laws of a jurisdiction
other than Jersey) where the parent entity or organisation is
listed on a regulated market; (ii) an entity which is listed on a
regulated market; and (iii) an entity which is wholly owned or
controlled by another entity which is regulated under the Financial
Services (Jersey) Law 1998 (the
FSJ Law) to carry
out certain limited classes of trust company business in respect of
To print this article, all you need is to be registered or login on Mondaq.com.
On 6 January 2021 the Financial Services (Disclosure and
Provision of Information) (Jersey) Law 2020 (the
DPI
Law) came into effect, together with the Financial
Services (Disclosure and Provision of Information) (Jersey) Order
(the
DPI Order) and the Financial Services
(Disclosure and Provision of Information) (Jersey) Regulations (the
DPI Regulations).
The DPI Law affects Jersey companies, foundations, incorporated
limited partnerships, limited liability companies, limited
liability partnerships and separate limited partnerships (both
existing and new). The DPI Law introduces a revised statutory
framework for reporting information on beneficial owners and